NFKB1 and cancer: A conducted study in 2015 revealed transcriptional suppression of PDLIM2 by KSHV leads to NF-κB and STAT3 activation and consequently tumorigenesis and tumor maintenance in KSHV-transformed endothelial cells and cancer cell lines [84].